Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy

ABSTRACT: INTRODUCTION/AIMS: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is characterized by progressive weakness and sensory loss, often affecting patient’s ability to walk and perform activities of daily living independently. Furthermore, patients often report fatigue and depr...

Descripción completa

Detalles Bibliográficos
Autores principales: Klehmet, Juliane, Tackenberg, Björn, Haas, Judith, Kieseier, Bernd C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214666/
https://www.ncbi.nlm.nih.gov/pubmed/37237267
http://dx.doi.org/10.1186/s12883-023-03223-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214666/
https://www.ncbi.nlm.nih.gov/pubmed/37237267
http://dx.doi.org/10.1186/s12883-023-03223-5

Ejemplares similares